Journals / Experimental Biomedical Research / 2022 / Cilt: 5 - Sayı: 1

The role of diffusion-weighted imaging on 3 tesla magnetic resonance in the clinical staging and pathological grading of clear cell renal carcinoma

Pages
125–134
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Clinical stage I and Fuhrman grade I had significantly higher ADC values than all groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To evaluate the contribution of the apparent diffusion coefficient (ADC) to distinguish between the four clinical stages and pathological grading in patients with clear cell renal cell carcinoma (RCC) on 3T MRI.
📊
Key Findings & Data:Methods: MRI of 93 patients with histopathological diagnosis of clear cell RCC were evaluated retrospectively.
💡
Conclusion & Impact:Clinical stage I and Fuhrman grade I had significantly higher ADC values than all groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: To evaluate the contribution of the apparent diffusion coefficient (ADC) to distinguish between the four clinical stages and pathological grading in patients with clear cell renal cell carcinoma (RCC) on 3T MRI. Methods: MRI of 93 patients with histopathological diagnosis of clear cell RCC were evaluated retrospectively. Clinical stage was evaluated according to American Joint Committee on Cancer and histopathological examination was evaluated according to the Fuhrman grading system. ADC values were compared for each clinical stage and pathological grade. Results: Clinical stages were I in 51 patients (54.8%), II in 14 patients (15%), III in 15 patients (16.1%), and IV in 13 patients (13.9%). The Fuhrman grade of the patients were I in 8 (8.6%) patients, II in 55 (59.1%) patients, III in 23 (24.7%) patients and IV in 7 (7.5%) patients. Clinical stage I and Fuhrman grade I had significantly higher ADC values than all groups (p

🔖

Cite This Article

EREN, H., BEDİR, R., GÜNDOĞDU, H., EROK, B. (2022). The role of diffusion-weighted imaging on 3 tesla magnetic resonance in the clinical staging and pathological grading of clear cell renal carcinoma. Experimental Biomedical Research, Cilt: 5 - Sayı: 1, 125–134. https://ajindex.com/articles/512593

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. NG CS, Wood CG, Silverman PM, et al. Renal cell carcinoma: diagnosis, staging, and surveillance. Am J Roentgenol. 2008;191(4):1220-32
  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30
  3. Federle MP, Jeffrey RB, Woodward PJ, et al. Diagnostic Imaging: Abdomen. Lippincott Williams & Wilkins, Amirsys; 2009. P.2-02
  4. Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;9(3):17009
  5. Graham TM, Stevens TM, Gordetsky JB. Pathology of renal tumors. In Diagnosis and surgical management of renal tumors. Springer, Cham; 2019. p. 13-38
  6. Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27 (suppl 5):58-68
  7. Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;11(1):71–77
  8. Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27(5):612–24
  9. Kıs N, Erok B. Diffusion weighted imaging in differentiation of the clear cell RCC from the major non-clear cell RCC subtypes. Eur J Clin Exp Med. 2021;19(3):215–20
  10. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol. 2007;188(6):1622–35
  11. Elmi A, Hedgire SS, Covarrubias D, et al. Apparent diffusion coefficient as a noninvasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol. 2013;68(10):524–31
  12. Arvinda HR, Kesavadas C, Sarma PS, et al. Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009;94(1):87–96
  13. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade.- J Magn Reson Imaging. 2008;28(3):720–26
  14. Yılmaz E, Erok B, Atca AÖ. Measurement of apparent diffusion coefficient in discrimination of benign and malignant axillary lymph nodes. Pol J Radiol. 2019;84:592-97
  15. Er HÇ, Peker E, Erden A, Öztürk E. The utility of diffusion-weighted imaging in differentiation of papillary and clear cell subtypes of renal cell carcinoma. Acta Oncol